trial · primary record
Fludarabine
Acute Leukemia
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 59 |
| Primary completion | 2025-10-09 |
| Primary endpoint | Graft-versus-host Disease Free Relapse Free (GRFS) at 1 Year |
| Registry ID | NCT04339101 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:36.494Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04339101
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.